Cargando…

Antibiotic Drug Nanocarriers for Probing of Multidrug ABC Membrane Transporter of Bacillus subtilis

[Image: see text] Multidrug membrane transporters can extrude a wide range of substrates, which cause multidrug resistance and ineffective treatment of diseases. In this study, we used three different sized antibiotic drug nanocarriers to study their size-dependent inhibitory effects against Bacillu...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherukuri, Pavan Kumar, Songkiatisak, Preeyaporn, Ding, Feng, Jault, Jean-Michel, Xu, Xiao-Hong Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990642/
https://www.ncbi.nlm.nih.gov/pubmed/32010837
http://dx.doi.org/10.1021/acsomega.9b03698
_version_ 1783492546933030912
author Cherukuri, Pavan Kumar
Songkiatisak, Preeyaporn
Ding, Feng
Jault, Jean-Michel
Xu, Xiao-Hong Nancy
author_facet Cherukuri, Pavan Kumar
Songkiatisak, Preeyaporn
Ding, Feng
Jault, Jean-Michel
Xu, Xiao-Hong Nancy
author_sort Cherukuri, Pavan Kumar
collection PubMed
description [Image: see text] Multidrug membrane transporters can extrude a wide range of substrates, which cause multidrug resistance and ineffective treatment of diseases. In this study, we used three different sized antibiotic drug nanocarriers to study their size-dependent inhibitory effects against Bacillus subtilis. We functionalized 2.4 ± 0.7, 13.0 ± 3.1, and 92.6 ± 4.4 nm silver nanoparticles (Ag NPs) with a monolayer of 11-amino-1-undecanethiol and covalently linked them with antibiotics (ofloxacin, Oflx). The labeling ratios of antibiotics with NPs are 8.6 × 10(2), 9.4 × 10(3), and 6.5 × 10(5) Oflx molecules per NP, respectively. We designed cell culture medium in which both BmrA and ΔBmrA cells grew and functioned normally while ensuring the stabilities of nanocarriers (nonaggregation). These approaches allow us to quantitatively study the dependence of their inhibitory effect against two isogenic strains of B. subtilis, WT (normal expression of BmrA) and ΔBmrA (deletion of bmrA), upon the NP size, antibiotic dose, and BmrA expression. Our results show that the inhibitory effects of nanocarriers highly depend on NP size and antibiotic dose. The same amount of Oflx on 2.4 ± 0.7, 13.0 ± 3.1, and 92.6 ± 4.4 nm nanocarriers shows the 3× lower, nearly the same, and 10× higher inhibitory effects than that of free Oflx, against both WT and ΔBmrA, respectively. Control experiments of the respective sized AgMUNH(2) NPs (absence of Oflx) show insignificant inhibitory effects toward both strains. Taken together, the results show multiple factors, such as labeling ratios, multivalent effects, and pharmacodynamics (Oflx localization and distribution), which might play the roles in the size-dependent inhibitory effects on the growth of both WT and ΔBmrA strains. Interestingly, the inhibitory effects of nanocarriers are independent of the expression of BmrA, which could be attributed to the higher efflux of nanocarriers by other membrane transporters in both strains.
format Online
Article
Text
id pubmed-6990642
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-69906422020-01-31 Antibiotic Drug Nanocarriers for Probing of Multidrug ABC Membrane Transporter of Bacillus subtilis Cherukuri, Pavan Kumar Songkiatisak, Preeyaporn Ding, Feng Jault, Jean-Michel Xu, Xiao-Hong Nancy ACS Omega [Image: see text] Multidrug membrane transporters can extrude a wide range of substrates, which cause multidrug resistance and ineffective treatment of diseases. In this study, we used three different sized antibiotic drug nanocarriers to study their size-dependent inhibitory effects against Bacillus subtilis. We functionalized 2.4 ± 0.7, 13.0 ± 3.1, and 92.6 ± 4.4 nm silver nanoparticles (Ag NPs) with a monolayer of 11-amino-1-undecanethiol and covalently linked them with antibiotics (ofloxacin, Oflx). The labeling ratios of antibiotics with NPs are 8.6 × 10(2), 9.4 × 10(3), and 6.5 × 10(5) Oflx molecules per NP, respectively. We designed cell culture medium in which both BmrA and ΔBmrA cells grew and functioned normally while ensuring the stabilities of nanocarriers (nonaggregation). These approaches allow us to quantitatively study the dependence of their inhibitory effect against two isogenic strains of B. subtilis, WT (normal expression of BmrA) and ΔBmrA (deletion of bmrA), upon the NP size, antibiotic dose, and BmrA expression. Our results show that the inhibitory effects of nanocarriers highly depend on NP size and antibiotic dose. The same amount of Oflx on 2.4 ± 0.7, 13.0 ± 3.1, and 92.6 ± 4.4 nm nanocarriers shows the 3× lower, nearly the same, and 10× higher inhibitory effects than that of free Oflx, against both WT and ΔBmrA, respectively. Control experiments of the respective sized AgMUNH(2) NPs (absence of Oflx) show insignificant inhibitory effects toward both strains. Taken together, the results show multiple factors, such as labeling ratios, multivalent effects, and pharmacodynamics (Oflx localization and distribution), which might play the roles in the size-dependent inhibitory effects on the growth of both WT and ΔBmrA strains. Interestingly, the inhibitory effects of nanocarriers are independent of the expression of BmrA, which could be attributed to the higher efflux of nanocarriers by other membrane transporters in both strains. American Chemical Society 2020-01-13 /pmc/articles/PMC6990642/ /pubmed/32010837 http://dx.doi.org/10.1021/acsomega.9b03698 Text en Copyright © 2020 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Cherukuri, Pavan Kumar
Songkiatisak, Preeyaporn
Ding, Feng
Jault, Jean-Michel
Xu, Xiao-Hong Nancy
Antibiotic Drug Nanocarriers for Probing of Multidrug ABC Membrane Transporter of Bacillus subtilis
title Antibiotic Drug Nanocarriers for Probing of Multidrug ABC Membrane Transporter of Bacillus subtilis
title_full Antibiotic Drug Nanocarriers for Probing of Multidrug ABC Membrane Transporter of Bacillus subtilis
title_fullStr Antibiotic Drug Nanocarriers for Probing of Multidrug ABC Membrane Transporter of Bacillus subtilis
title_full_unstemmed Antibiotic Drug Nanocarriers for Probing of Multidrug ABC Membrane Transporter of Bacillus subtilis
title_short Antibiotic Drug Nanocarriers for Probing of Multidrug ABC Membrane Transporter of Bacillus subtilis
title_sort antibiotic drug nanocarriers for probing of multidrug abc membrane transporter of bacillus subtilis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990642/
https://www.ncbi.nlm.nih.gov/pubmed/32010837
http://dx.doi.org/10.1021/acsomega.9b03698
work_keys_str_mv AT cherukuripavankumar antibioticdrugnanocarriersforprobingofmultidrugabcmembranetransporterofbacillussubtilis
AT songkiatisakpreeyaporn antibioticdrugnanocarriersforprobingofmultidrugabcmembranetransporterofbacillussubtilis
AT dingfeng antibioticdrugnanocarriersforprobingofmultidrugabcmembranetransporterofbacillussubtilis
AT jaultjeanmichel antibioticdrugnanocarriersforprobingofmultidrugabcmembranetransporterofbacillussubtilis
AT xuxiaohongnancy antibioticdrugnanocarriersforprobingofmultidrugabcmembranetransporterofbacillussubtilis